Rare adenocarcinoma of the breast
ORPHA:213528DiseaseAdult
Эпидемиология24
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | 1-9 / 100 000 | 3.55 | Europe | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.898 | Lithuania | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.325 | Austria | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.221 | Belgium | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.397 | Bulgaria | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.175 | Croatia | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.717 | Czech Republic | Value and class |
| Annual incidence | 1-9 / 100 000 | 3.371 | Estonia | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.615 | Finland | Value and class |
| Annual incidence | 1-9 / 100 000 | 3.812 | Germany | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.428 | Iceland | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.305 | Ireland | Value and class |
| Annual incidence | 1-9 / 100 000 | 4.103 | Italy | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.191 | Latvia | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.199 | Malta | Value and class |
| Annual incidence | 1-9 / 100 000 | 3.017 | Norway | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.812 | Poland | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.697 | Portugal | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.171 | Slovakia | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.315 | Slovenia | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.142 | Spain | Value and class |
| Annual incidence | 1-9 / 100 000 | 3.187 | Switzerland | Value and class |
| Annual incidence | 1-9 / 100 000 | 3.264 | Netherlands | Value and class |
| Annual incidence | 1-9 / 100 000 | 3.638 | United Kingdom | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)